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▼Several methods exist for the quantification of mRNAs.
The classic methods, such as northern blots and RNAse pro-
tection assay, have been improved over the years and have
provided reliable results but they share the drawback of hav-
ing too low sensitivity for studies in small tissue samples.
Recently the development of competitive RT–PCR assays
has provided a valuable tool for this type of study (Ref. 1, 2),
even if the reliability and accuracy of these assays has been
a matter of intense discussion during the past years. Today
the use of RNA competitors as internal standards in all steps
of the reaction including the RT step is generally accepted
as a reliable and sensitive method for the quantification of
mRNAs (for review see Ref. 3). However, a major problem
of competitive PCR in terms of effort and time is the gener-
ation of suitable competitor fragments. Here, we describe a
streamlined method for the generation of RNA competitors
by a straightforward PCR-based approach. The use of com-
mercially avaible kits in most steps of the procedure allows
the easy and efficient generation of RNA-competitors for
use in competitive RT–PCR.
A schematic outline of the method is given in Figure
1. Three primer sites are used in this method, two nested
forward primers (Fw1 and Fw2), with a distance of approxi-
mately 100 bp, and one reverse primer (Rev). The PCR assay
using Fw1 and Rev should be optimized well (Ref. 4) and
only generate a single product that is verified by sequencing
or restriction analysis.
In the first round of PCR a fragment representing the
native mRNA is generated by conventional RT–PCR using
Fw1 and Rev as primers. This fragment is purified on a gel
and eluted by use of an extraction kit [e.g. Quiaex II (Quia-
gen, Hilden, Germany)]. The purified first-round product is
subjected to a second round of PCR using a hybrid primer
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(containing Fw1 at the 5′ end and Fw2 at the 3′ end) as for-
ward primer and Rev as reverse primer. This second round
of PCR results in a product containing Fw1- and Rev-primer
sites that are about 100 bp closer to each other (i.e. the dis-
tance between Fw1 and Fw2), when compared with the
native sequence.
Using a TA-cloning strategy [e.g. pGEM-T Vector system
(Promega, Madison, Wisconsin, USA)], the fragment can be
cloned easily into a plasmid vector containing suitable pro-
motors for the in vitro transcription of RNA, like T7 or SP6.
The identity of the insert and the extent of the deletion
is finally verified by sequencing. After linearization of the
plasmid, sense-competitor RNA is transcribed in vitro using
a suitable kit [e.g. Riboprobe (Promega)] and the resulting
RNA mimics are purified from the remaining plasmid tem-
plate by DNAse 1 digestion. After dilution to appropriate
concentration and control experiments that ensure equal
and parallel amplification of competitor and native tem-
plates, the RNA competitor is ready for use in competitive
RT–PCR (Ref. 2).
The method outlined above has been used in our labora-
tory to generate a series of RNAmimics for rat ATP receptors
(Ref. 5). Figure 2 gives an example of the use of a com-
petitor for rat P2Y2 receptors generated with the method
described here. Compared with other methods (Ref. 1, 2)
the present strategy has several advantages. First, the use
of a PCR-based, two-step strategy allows the use of exist-
ing and well-established PCR assays, which can be found
in many laboratories. Second, no time-consuming and la-
borious cloning or subcloning steps are required except for
the final cloning of the competitor. All steps of the pro-
cedure, including the cloning step, can be streamlined by
convenient commercially avaible kits, thus, even making it
possible for laboratories with little experience in molecular
biology to set up competitive RT–PCR assays. In addition,
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FIGURE 1. Flowchart for the generation of RNA-competitors. The primers used are: PCR-round 1. Fw1 as forward and Rev as reverse; PCR-round 2.
Hybridprimer Fw1/Fw2 as forward and Rev as reverse. After TA-cloning the competitor fragment is transcribed in vitro into sense competitor RNA.
FIGURE 2. Example of a competitive RT–PCR method for rat P2Y2
receptors. 200 ng of total RNA isolated from cultured rat
smooth-muscle cells was mixed with a 1:10 dilution series of
competitor RNA (ranging from 50 000 copies (lane 1) to 500 000×103
copies (lane 5). Competitive RT–PCR was performed as described
(Ref. 5). The PCR products were separated on a 2% agarose gel (insert)
and analyzed densitometrically before the ratio of sample (538 bp) and
competitor (452 bp) band intensities in each reaction was plotted
against competitor numbers. Using linear regression, the eqivalence
point (log ratio=0) in this experiment (i.e. the number of P2Y2 mRNA
molecules in the sample) was determined as 3160×103 copies/µg total
RNA. M=100 bp size marker.
the use of competitors that yield a 100 bp deletion com-
pared with the native sequence, combines convenient anal-
ysis on conventional agarose gels with minimal sequence
differences to the native RNA, thus, ensuring parallel am-
plification. We hope that this method will help to over-
come some technical problems in establishing competitive
RT–PCR assays.
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